India crosses the landmark of 10 crore total tests

▴ India crosses the landmark of 10 crore total tests
Nearly 14.5 lakh COVID tests conducted in the last 24 hrs

India has demonstrated an exponential increase in the number of COVID-19 cumulative tests since Jan 2020. It has crossed the landmark of 10 crore (10,01,13,085) total tests today.

In an another achievement, 14,42,722 tests were conducted in the last 24 hours.

The country’s testing capacities have multiplied manifold with nearly 2000 labs across the country and with collaborative efforts of the Centre and State/UT governments. More than 15 lakh samples can be tested every day.

Progressive countrywide expansion in testing infrastructure has played a crucial role in the steep rise of testing numbers. With 1989 testing labs in the country including 1122 Government laboratories and 867 Private laboratories, the daily testing capacity has got a substantial boost.

High level of comprehensive testing on a sustained basis has also resulted in bringing down the national positivity rate. This indicates that the rate of spread of infection is being effectively contained. The cumulative rate continues to decline as total tests cross 10 crore. The national positivity rate is 7.75% today.

This is a result of successful TEST, TRACK, TRACE, TREAT and TECHNOLOGY strategy of the Central government effectively followed by States/UTs.

Higher testing across wide regions has resulted in early identification of positive cases, prompt tracking through efficient surveillance and tracing, and timely & effective treatment in homes/facilities and in hospitals for severe cases. These measures in tandem eventually lead to lower mortality rate.

The last 1 crore tests were conducted in 9 days. 15 States and UTs are exhibiting higher Positivity Rate compared to the national figure, indicating the need for higher levels of comprehensive testing in these regions.

Tags : #India #COVID-19Pandemic #LatestCOVIDNews24thOct #COVID-19Test #TestTrackTreatTechnology #PositivityRate

About the Author


Team Medicircle

Related Stories

04 May

Centre waives off IGST on import of Corona related medical supplies

To facilitate procurement government let go duty on Covid imports

View
30 Apr

Maharashtra health minister Rajesh Tope warns of 3rd wave of Covid-19

Maharashtra prepares for 3rd wave

View
24 Apr

Remdesivir – Antiviral drug for treatment of COVID 19

“Remdesivir has been helpful in treating the viral infection SARS - CoV 2, however, a combination of drug therapy that includes vitamin supplements, steroids, oxygen supply, blood thinner is being used to treat Covid-19 patients.”

View
20 Apr

Now all adults are eligible for vaccination: Central Government

Government opens up COVID-19 vaccination for all above 18 years of age from May 1

View
15 Apr

Centre approves increase in production of Remdesivir and reducing its prices

ED has been directed to act against black marketing of Remdesivir

View
12 Mar

Steps being taken to reduce difference between Selling price & actual price of Remdesivir injection: Maharashtra Minister

The difference in the selling price of Remdesivir from different outlets to be addressed

View
14 Jan

Bharat Bioech ships Covaxin to 11 cities

Covaxin the inactivated vaccine reaches India cities, though final trial reports are awaited

View
10 Nov

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids and shuns remdesivir.

View
23 Oct

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19

View
17 Oct

Remdesivir useless for severe Covid-19 patients : WHO

The search for effective drug continues for severely affected Covid patients

View

-Advertisements-




Trending Now

Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025